Specificity of ABCA7-mediated lipid efflux and its effects on intracellular lipid metabolism in neural cells
ABCA7介导的脂质流出的特异性及其对神经细胞细胞内脂质代谢的影响
基本信息
- 批准号:10591201
- 负责人:
- 金额:$ 22.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:ATP-binding cassette transportAffectAfrican ancestryAgeAge YearsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimalsArchitectureAstrocytesBiochemicalBrainCell membraneCellsCessation of lifeCholesterolCholesterol HomeostasisChromosome 21DataDementiaDimensionsDiseaseDown SyndromeEarly Onset Familial Alzheimer&aposs DiseaseElectrospray IonizationEngineeringEtiologyEuropean ancestryExhibitsGenesGeneticGenetic Predisposition to DiseaseGenetic studyGlioblastomaHealthcare SystemsHigh Density LipoproteinsHippocampusHumanIndividualInduced pluripotent stem cell derived neuronsInvestigationKnowledgeLabelLate Onset Alzheimer DiseaseLecithinLinkLipidsLongevityMass Spectrum AnalysisMeasuresMediatingMediatorMetabolicMicrogliaNerve DegenerationNeuroblastomaNeuronsParietal LobePathogenesisPathologicPathologyPerformancePhospholipidsPhosphotransferasesPhysiologyPopulationProductivityProteinsPublishingRadioactiveResearch PersonnelRiskRoleShotgunsSpecificityTestingThin Layer ChromatographyTissuesTrisomyVariantcomparativeextracellulargene functiongenome wide association studyhigh density lipoprotein-1lipid metabolismlipidomicsloss of functionloss of function mutationmembermouse modelneuralneuron lossparticlepreferencetau Proteins
项目摘要
Project Summary/Abstract
Alzheimer's disease (AD) dementia has emerged as a major burden on the healthcare system and a major
barrier to human longevity, especially productive human longevity. Genetics of familial early-onset AD,
pathological changes in the brain of sporadic late-onset AD patients and pathological changes in the brain of
individuals with Down syndrome, who frequently have increased expression of amyloid precursor protein (APP)
owing to partial trisomy of chromosome 21, all point to APP and its cleavage product amyloid β (Aβ) peptide as
major causative factors in AD pathogenesis. However, other factors may also play a role. The genome-wide
association studies (GWAS) of the architecture of common genetic predisposition to AD, genetic investigations
of rare loss-function mutations and studies in mouse models of AD have implicated ATP-binding cassette
transport subfamily A member 7 (ABCA7) in AD pathogenesis. A closely related protein, ATP-binding cassette
transport subfamily A member 1 (ABCA1) has been implicated in AD in the GWAS and animal studies. In our
preliminary data, we show that individuals with low ABCA7 protein levels have a greater risk for developing AD
pathology. Both ABCA1 and ABCA7 mediate formation of high-density lipoprotein (HDL) particles from cell
lipids. In preliminary data, we show that ABCA7- and ABCA1-HDL significantly differ in the lipid composition.
Recently, we published the altered lipidostasis hypothesis that draws on the paradigms provided by ABCA1
and another ABC A transporter, ABCA4, and poses the existence of a neurodegenerative lipid that
continuously arises during normal physiology and promotes AD pathogenesis when it is not eliminated from
neural cells by ABCA7. ABCA1 and ABCA4 eliminate from specific cells deleterious lipids that these cells
accumulate during normal function. The purpose of the present exploratory project is to conduct comparative
ABCA7 vs ABCA1 studies in specificity of lipid efflux in neural cells and to test the prediction of the lipidostasis
hypothesis of AD that in the neural tissue ABCA7 mediates efflux of a specific lipid species (i.e., the
neurodegenerative lipid) that is not effluxed significantly by ABCA1. To test this prediction, we will use
metabolic radioactive labeling of lipids/high performance thin layer chromatography (HPTLC) and
multidimensional electrospray
ionization
`shotgun' mass spectrometry lipidomics to compare ABCA7- and
ABCA1-mediated lipid efflux/HDL and the effects that this efflux/HDL formation has on the lipid composition of
the plasma membrane and whole cell in microglia C20, astrocyte glioblastoma A172 and neuroblastoma SK-N-
SH cells inducibly expressing ABCA7 or ABCA1.
项目摘要/摘要
阿尔茨海默氏病(AD)痴呆症已成为医疗系统的主要伯恩(Burnen)
人类寿命的障碍,尤其是生产力的人类寿命。家庭早发广告的遗传学,
零星发作的AD患者大脑的病理变化以及大脑的病理变化
患有唐氏综合症的个体,他们经常增加淀粉样前体蛋白(APP)的表达
由于染色体21的部分三体三体,全部指向APP及其裂解产物淀粉样β(Aβ)胡椒
AD发病机理中主要基因组的主要因素。但是,其他因素也可能发挥作用。
对AD的常见遗传易感性结构,遗传研究的结构(GWAS)
AD小鼠模型中罕见的损耗功能突变和研究已实现ATP结合盒
在AD发病机理中转运亚家族7(ABCA7)。紧密相关的蛋白质,ATP结合盒
在GWAS和动物研究中,在AD中隐含了转运亚家族1(ABCA1)。在我们的
初步数据,我们表明,ABCA7蛋白水平较低的个体具有更大的开发AD风险
病理。 ABCA1和ABCA7介导了细胞的高密度脂蛋白(HDL)颗粒的形成
脂质。在初步数据中,我们表明脂质组成中的ABCA7-和ABCA1-HDL显着差异。
最近,我们发表了改变的Lipidostasis假设,该假设借鉴了ABCA1提供的范例
另一个ABC是转运蛋白ABCA4,并构成了神经退行性脂质的存在
在正常生理过程中连续出现,并在没有从中消除AD发病机理
ABCA7神经细胞。 ABCA1和ABCA4从这些细胞的特定细胞有害脂质中消除
在正常功能期间积聚。本探索项目的目的是进行比较
ABCA7与ABCA1在神经细胞中脂质外排的特异性研究并测试脂肪替代的预测
AD的假设是,在神经组织中,ABCA7介导了特定脂质物种的外排(即
神经退行性脂质)未被ABCA1显着排出。为了测试这一预测,我们将使用
脂质/高性能薄层色谱(HPTLC)的代谢放射性标记和
多维电喷雾
电离
“ shot弹枪”质谱脂肪组学以比较ABCA7-和
ABCA1介导的脂质外排/HDL以及该外排/HDL形成对脂质组成的影响
小胶质细胞C20中的质膜和全细胞
SH细胞表达ABCA7或ABCA1。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas Lyssenko其他文献
Nicholas Lyssenko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas Lyssenko', 18)}}的其他基金
Toward precision medicine: modulation of ABCA7 associated risk of Alzheimer's disease by ancestry
迈向精准医疗:通过血统调节 ABCA7 相关阿尔茨海默病风险
- 批准号:
10323669 - 财政年份:2021
- 资助金额:
$ 22.32万 - 项目类别:
A mouse model and iPS cells to study hyperactive ABCA1 in the eye in age-related macular degeneration
小鼠模型和 iPS 细胞研究年龄相关性黄斑变性中过度活跃的 ABCA1
- 批准号:
10362536 - 财政年份:2021
- 资助金额:
$ 22.32万 - 项目类别:
ABCA1-mediated biogenesis of nascent HDL particles
ABCA1 介导的新生 HDL 颗粒的生物发生
- 批准号:
8061006 - 财政年份:2011
- 资助金额:
$ 22.32万 - 项目类别:
ABCA1-mediated biogenesis of nascent HDL particles
ABCA1 介导的新生 HDL 颗粒的生物发生
- 批准号:
8448765 - 财政年份:2011
- 资助金额:
$ 22.32万 - 项目类别:
ABCA1-mediated biogenesis of nascent HDL particles
ABCA1 介导的新生 HDL 颗粒的生物发生
- 批准号:
8262670 - 财政年份:2011
- 资助金额:
$ 22.32万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 22.32万 - 项目类别:
Leveraging pleiotropy to develop polygenic risk scores for cardiometabolic diseases
利用多效性开发心脏代谢疾病的多基因风险评分
- 批准号:
10797389 - 财政年份:2023
- 资助金额:
$ 22.32万 - 项目类别:
Structural Variation analysis of Orofacial Cleft associated genomic regions in African and Asian populations
非洲和亚洲人群口面部裂相关基因组区域的结构变异分析
- 批准号:
10643334 - 财政年份:2023
- 资助金额:
$ 22.32万 - 项目类别:
Role and Theranostics Potential of Enolase in Prostate Cancer Health Disparities
烯醇化酶在前列腺癌健康差异中的作用和治疗潜力
- 批准号:
10649164 - 财政年份:2023
- 资助金额:
$ 22.32万 - 项目类别:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
- 批准号:
10822651 - 财政年份:2023
- 资助金额:
$ 22.32万 - 项目类别: